Compremium recently won FDA Breakthrough Device designation for its noninvasive Quantis CVP (central venous pressure) ...
The assessment of the inferior vena cava (IVC) and central venous pressure (CVP) has emerged as a pivotal aspect in the optimisation of haemodynamic management across a range of clinical settings.